Antiarrhythmics Part 2: Potassium Blockers, Beta & Calcium Blockers
One antiarrhythmic is so effective it can calm almost any rhythm — and so toxic it slowly stains the skin blue, scars the lungs, and derails the thyroid. Amiodarone is the strange miracle-and-menace of heart-rhythm drugs, and it doesn't even respect the classification system. Around it sit the reliable, safer workhorses: the beta blockers and calcium blockers that simply slow the heart's gatekeeper node.
A patient on long-term amiodarone comes to clinic with a slate-grey-blue tint to his face, a dry cough, and blood tests showing his thyroid has gone haywire. None of this is a coincidence — it's the price of the most effective antiarrhythmic drug we have. Amiodarone controls rhythms that defeat other drugs, but it slowly accumulates in nearly every organ and poisons them. This double nature — supreme effectiveness, serious toxicity — makes it the centrepiece of the potassium-blocker class and a lesson in the cost of power.
Class III: prolonging repolarization
Class III drugs block potassium channels. By blocking the phase-3 potassium channel, Class III drugs prolong the action potential and the refractory period — making it harder for an abnormal rhythm to sustain itself. Because they lengthen repolarization, they prolong the QT interval and can (for most of them) cause torsades de pointes. Amiodarone is the giant here, and it's peculiar: although classed as III, it actually blocks sodium, potassium, calcium, AND beta receptors — a bit of all four classes. That's why it's so broadly effective for both atrial and ventricular arrhythmias. Oddly, despite prolonging the QT, amiodarone rarely causes torsades. Sotalol combines potassium blockade with beta blockade (so it's also Class II) and does carry a real torsades risk.
Amiodarone is a drug you monitor for life. Its huge fat-solubility gives it a half-life of weeks and lets it deposit throughout the body, causing a signature list of toxicities: lung fibrosis, thyroid disease in both directions (it's packed with iodine), liver injury, a blue-grey skin discolouration, corneal deposits, sun sensitivity, and nerve damage. It also raises the levels of warfarin and digoxin. So patients need baseline and periodic checks of the lungs, thyroid, liver, and eyes. The most effective antiarrhythmic demands the most vigilant monitoring — that's the trade.
Class II & IV: slowing the gate
The other two classes are the reliable, safer rate-controllers. Class II — the beta blockers (metoprolol, bisoprolol, esmolol) — reduce the sympathetic drive on the heart, slowing the SA node's rate and the AV node's conduction. They're workhorses for controlling the rate in atrial fibrillation, calming sympathetically-driven arrhythmias, and preventing sudden death after a heart attack. Class IV — the non-dihydropyridine calcium channel blockers verapamil and diltiazem — slow conduction through the AV node, so they too control the ventricular rate in atrial fibrillation and terminate certain supraventricular tachycardias. Both classes work by slowing the heart's electrical gatekeeper rather than by fiddling with the muscle's own action potential, which makes them predictable and comparatively safe.
- Class III block K⁺ → prolong the action potential & QT (torsades risk for most).
- Amiodarone hits all four classes — very effective, broad, but multi-organ toxic; monitor for life.
- Amiodarone raises warfarin & digoxin levels; despite QT prolongation, torsades is rare.
- Class II (beta blockers) & Class IV (verapamil/diltiazem) slow the AV node → rate control.
- Sotalol = potassium blocker + beta blocker; carries a real torsades risk.
- Starting amiodarone without baseline lung, thyroid, liver & eye checks and ongoing monitoring.
- Forgetting amiodarone raises warfarin and digoxin levels — adjust and monitor them.
- Combining a Class IV drug (verapamil/diltiazem) with a beta blocker — severe bradycardia/heart block.
- Overlooking sotalol's torsades risk — it prolongs the QT.
Which antiarrhythmic acts on all four Vaughan-Williams classes and requires lifelong organ monitoring?
- Class III block K⁺, prolonging the action potential & QT (torsades risk for most).
- Amiodarone (all four classes) is broadly effective but multi-organ toxic — monitor lungs, thyroid, liver, eyes.
- Class II (beta blockers) & IV (verapamil/diltiazem) slow the AV node for rate control.
- Don't combine verapamil/diltiazem with a beta blocker (severe bradycardia/block).
- Katzung BG. Basic & Clinical Pharmacology — Agents Used in Cardiac Arrhythmias (Class II, III, IV).
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Antiarrhythmic drugs; amiodarone.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Antidysrhythmic drugs.
- ACC/AHA & ESC guidelines — Rate control & antiarrhythmic therapy.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Antiarrhythmic drugs.
